These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25030918)

  • 21. Technology evaluation: SAGE, Genzyme molecular oncology.
    Bartlett J
    Curr Opin Mol Ther; 2001 Feb; 3(1):85-96. PubMed ID: 11249736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction of small RNA cDNA libraries for high-throughput sequencing.
    Lu C; Shedge V
    Methods Mol Biol; 2011; 729():141-52. PubMed ID: 21365488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Essential gene profiles in breast, pancreatic, and ovarian cancer cells.
    Marcotte R; Brown KR; Suarez F; Sayad A; Karamboulas K; Krzyzanowski PM; Sircoulomb F; Medrano M; Fedyshyn Y; Koh JLY; van Dyk D; Fedyshyn B; Luhova M; Brito GC; Vizeacoumar FJ; Vizeacoumar FS; Datti A; Kasimer D; Buzina A; Mero P; Misquitta C; Normand J; Haider M; Ketela T; Wrana JL; Rottapel R; Neel BG; Moffat J
    Cancer Discov; 2012 Feb; 2(2):172-189. PubMed ID: 22585861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome-wide identification of microRNAs in Medicago truncatula by high-throughput sequencing.
    Wang TZ; Zhang WH
    Methods Mol Biol; 2013; 1069():67-80. PubMed ID: 23996309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of methods for quantitative comparison of pooled shRNAs by mass sequencing.
    Hoshiyama H; Tang J; Batten K; Xiao G; Rouillard JM; Shay JW; Xie Y; Wright WE
    J Biomol Screen; 2012 Feb; 17(2):258-65. PubMed ID: 21956173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic lethal genetic screens in Ras mutant cancers.
    Yu B; Luo J
    Enzymes; 2013; 34 Pt. B():201-19. PubMed ID: 25034106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of Drug Resistance Using Kinome-Wide Functional Screens.
    Singleton KR; Earley KT; Heasley LE
    Methods Mol Biol; 2017; 1636():163-177. PubMed ID: 28730479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A high-throughput siRNA screening platform to identify MYC-synthetic lethal genes as candidate therapeutic targets.
    Grandori C
    Methods Mol Biol; 2013; 1012():187-200. PubMed ID: 24006065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencing.
    Sims D; Mendes-Pereira AM; Frankum J; Burgess D; Cerone MA; Lombardelli C; Mitsopoulos C; Hakas J; Murugaesu N; Isacke CM; Fenwick K; Assiotis I; Kozarewa I; Zvelebil M; Ashworth A; Lord CJ
    Genome Biol; 2011 Oct; 12(10):R104. PubMed ID: 22018332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of microRNA expression with next-generation sequencing.
    Eminaga S; Christodoulou DC; Vigneault F; Church GM; Seidman JG
    Curr Protoc Mol Biol; 2013 Jul; Chapter 4():Unit 4.17. PubMed ID: 23821442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional identification of cancer-relevant genes through large-scale RNA interference screens in mammalian cells.
    Brummelkamp TR; Berns K; Hijmans EM; Mullenders J; Fabius A; Heimerikx M; Velds A; Kerkhoven RM; Madiredjo M; Bernards R; Beijersbergen RL
    Cold Spring Harb Symp Quant Biol; 2004; 69():439-45. PubMed ID: 16117679
    [No Abstract]   [Full Text] [Related]  

  • 32. The Power Decoder Simulator for the Evaluation of Pooled shRNA Screen Performance.
    Stombaugh J; Licon A; Strezoska Ž; Stahl J; Anderson SB; Banos M; van Brabant Smith A; Birmingham A; Vermeulen A
    J Biomol Screen; 2015 Sep; 20(8):965-75. PubMed ID: 25777298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Application of RNAi library to oncology investigation].
    Weng DH; Wang SX; Ma D
    Ai Zheng; 2008 Nov; 27(11):1229-32. PubMed ID: 19000460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of microRNAs from goat (Capra hircus) by Solexa deep-sequencing technology.
    Ling YH; Ding JP; Zhang XD; Wang LJ; Zhang YH; Li YS; Zhang ZJ; Zhang XR
    Genet Mol Res; 2013 Jun; 12(2):1951-61. PubMed ID: 23913378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Designing, optimizing, and implementing high-throughput siRNA genomic screening with glioma cells for the discovery of survival genes and novel drug targets.
    Thaker NG; McDonald PR; Zhang F; Kitchens CA; Shun TY; Pollack IF; Lazo JS
    J Neurosci Methods; 2010 Jan; 185(2):204-12. PubMed ID: 19782703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of a pooled shRNA library for functional genomics screens.
    Papadopoulos D; Ade CP; Eilers M
    STAR Protoc; 2022 Mar; 3(1):101183. PubMed ID: 35243374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction of equalized short hairpin RNA library from human brain cDNA.
    Xu L; Li J; Liu L; Lu L; Gao J; Li X
    J Biotechnol; 2007 Feb; 128(3):477-85. PubMed ID: 17187888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BAGEL: a computational framework for identifying essential genes from pooled library screens.
    Hart T; Moffat J
    BMC Bioinformatics; 2016 Apr; 17():164. PubMed ID: 27083490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzymatically prepared RNAi libraries.
    Buchholz F; Kittler R; Slabicki M; Theis M
    Nat Methods; 2006 Sep; 3(9):696-700. PubMed ID: 16929314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype.
    Bossi D; Cicalese A; Dellino GI; Luzi L; Riva L; D'Alesio C; Diaferia GR; Carugo A; Cavallaro E; Piccioni R; Barberis M; Mazzarol G; Testori A; Punzi S; Pallavicini I; Tosti G; Giacó L; Melloni G; Heffernan TP; Natoli G; Draetta GF; Minucci S; Pelicci P; Lanfrancone L
    Cancer Discov; 2016 Jun; 6(6):650-63. PubMed ID: 27179036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.